Autoinjectors

Autoinjectors

Global Autoinjectors Market to Reach $168.2 Billion by 2030
The global market for Autoinjectors estimated at US$59.7 Billion in the year 2023, is expected to reach US$168.2 Billion by 2030, growing at a CAGR of 13.8% over the period 2023-2030. Rheumatoid Arthritis Therapy, one of the segments analyzed in the report, is expected to record 13.8% CAGR and reach US$47.6 Billion by the end of the analysis period. Growth in the Anaphylaxis Therapy segment is estimated at 13.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $16.1 Billion, While China is Forecast to Grow at 18.4% CAGR
The Autoinjectors market in the U.S. is estimated at US$16.1 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$40.4 Billion by the year 2030 trailing a CAGR of 18.4% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 11.7% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 10.9% CAGR.

Introducing Our Exciting New Report Features for 2024
» Full access to influencer engagement stats
» Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
» Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
» Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
» Complimentary report updates for one year
» Competitor coverage with global market shares of major players
» Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
» Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 42 Featured) -
  • AbbVie, Inc.
  • Amgen, Inc.
  • Antares Pharma, Inc.
  • Becton, Dickinson and Company
  • Consort Medical PLC
  • Eli Lilly and Company
  • Haselmeier GmbH
  • Mylan NV
  • Owen Mumford Ltd.
  • SHL Group
  • Teva Pharmaceutical Industries Ltd.
  • Ypsomed AG
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Autoinjectors – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Chronic Diseases Spurs Growth in Autoinjector Demand
Technological Innovations in Autoinjector Design Propel Market Expansion
Shift Toward Patient Self-Administration Expands Addressable Market for Autoinjectors
Growing Use of Biologics and Biosimilars Strengthens Business Case for Autoinjectors
Increased Focus on Patient Safety and Compliance Drives Adoption of Smart Autoinjectors
Advancements in Needle Technology Propel Demand for Pain-Free Autoinjectors
Rising Healthcare Costs and Demand for Homecare Solutions Drive Autoinjector Market Growth
Integration of Digital Health Technologies Throws the Spotlight on Connected Autoinjectors
Expanding Therapeutic Applications of Autoinjectors Propels Market Adoption
Increasing Awareness of Anaphylaxis Management Drives Demand for Epinephrine Autoinjectors
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Rheumatoid Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Rheumatoid Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Rheumatoid Arthritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Multiple Sclerosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Anaphylaxis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Anaphylaxis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Anaphylaxis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Autoinjectors Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 20: World Recent Past, Current & Future Analysis for Disposable Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Disposable Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Disposable Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Reusable Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Reusable Autoinjectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Reusable Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Ambulatory Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Ambulatory Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Ambulatory Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
CANADA
TABLE 44: Canada Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 47: Canada Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
JAPAN
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 53: Japan Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
CHINA
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 62: China Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 65: China Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
EUROPE
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 71: Europe Recent Past, Current & Future Analysis for Autoinjectors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Autoinjectors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
FRANCE
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 83: France Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 86: France Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
GERMANY
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 92: Germany Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 95: Germany Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
ITALY
TABLE 101: Italy Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 104: Italy Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
UNITED KINGDOM
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 110: UK Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 113: UK Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
SPAIN
TABLE 119: Spain Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Spain Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Spain 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 122: Spain Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Spain Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Spain 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 125: Spain Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Spain Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Spain 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
RUSSIA
TABLE 128: Russia Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Russia Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Russia 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 131: Russia Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Russia Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Russia 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 134: Russia Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Russia Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Russia 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of Europe Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of Europe 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of Europe Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of Europe 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of Europe Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of Europe 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 147: Asia-Pacific Historic Review for Autoinjectors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Asia-Pacific 16-Year Perspective for Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Asia-Pacific 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Asia-Pacific Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Asia-Pacific 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Asia-Pacific Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Asia-Pacific 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
AUSTRALIA
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 158: Australia Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Australia Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Australia 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 161: Australia Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Australia Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Australia 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 164: Australia Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Australia Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Australia 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
INDIA
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 167: India Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: India Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: India 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 170: India Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: India Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: India 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 173: India Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: India Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: India 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 176: South Korea Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: South Korea Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: South Korea 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 179: South Korea Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: South Korea Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: South Korea 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 182: South Korea Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: South Korea Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: South Korea 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Rest of Asia-Pacific Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Rest of Asia-Pacific Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Rest of Asia-Pacific Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
LATIN AMERICA
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 194: Latin America Recent Past, Current & Future Analysis for Autoinjectors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 195: Latin America Historic Review for Autoinjectors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Latin America 16-Year Perspective for Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 197: Latin America Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Latin America 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 200: Latin America Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Latin America Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Latin America 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 203: Latin America Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Latin America Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Latin America 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 206: Argentina Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Argentina Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Argentina 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 209: Argentina Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Argentina Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Argentina 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 212: Argentina Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Argentina Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Argentina 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
BRAZIL
TABLE 215: Brazil Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 216: Brazil Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 217: Brazil 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 218: Brazil Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 219: Brazil Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 220: Brazil 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 221: Brazil Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 222: Brazil Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 223: Brazil 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
MEXICO
TABLE 224: Mexico Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 225: Mexico Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 226: Mexico 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 227: Mexico Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 228: Mexico Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 229: Mexico 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 230: Mexico Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 231: Mexico Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 232: Mexico 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 234: Rest of Latin America Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 235: Rest of Latin America 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 237: Rest of Latin America Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 238: Rest of Latin America 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 240: Rest of Latin America Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 241: Rest of Latin America 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
MIDDLE EAST
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 242: Middle East Recent Past, Current & Future Analysis for Autoinjectors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 243: Middle East Historic Review for Autoinjectors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 244: Middle East 16-Year Perspective for Autoinjectors by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 245: Middle East Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 247: Middle East 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 248: Middle East Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 249: Middle East Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 250: Middle East 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 251: Middle East Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 252: Middle East Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 253: Middle East 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
IRAN
TABLE 254: Iran Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 255: Iran Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 256: Iran 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 257: Iran Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 258: Iran Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 259: Iran 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 260: Iran Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 261: Iran Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 262: Iran 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
ISRAEL
TABLE 263: Israel Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 264: Israel Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 265: Israel 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 266: Israel Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 267: Israel Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 268: Israel 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 269: Israel Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 270: Israel Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 271: Israel 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 273: Saudi Arabia Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 274: Saudi Arabia 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 276: Saudi Arabia Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 277: Saudi Arabia 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 279: Saudi Arabia Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 280: Saudi Arabia 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 281: UAE Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 282: UAE Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 283: UAE 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 284: UAE Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 285: UAE Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 286: UAE 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 287: UAE Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 288: UAE Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 289: UAE 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 291: Rest of Middle East Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 292: Rest of Middle East 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 294: Rest of Middle East Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 295: Rest of Middle East 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 297: Rest of Middle East Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 298: Rest of Middle East 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
AFRICA
Autoinjectors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 299: Africa Recent Past, Current & Future Analysis for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 300: Africa Historic Review for Autoinjectors by Therapy - Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 301: Africa 16-Year Perspective for Autoinjectors by Therapy - Percentage Breakdown of Value Sales for Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, Diabetes and Other Therapies for the Years 2014, 2024 & 2030
TABLE 302: Africa Recent Past, Current & Future Analysis for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 303: Africa Historic Review for Autoinjectors by Type - Disposable Autoinjectors and Reusable Autoinjectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 304: Africa 16-Year Perspective for Autoinjectors by Type - Percentage Breakdown of Value Sales for Disposable Autoinjectors and Reusable Autoinjectors for the Years 2014, 2024 & 2030
TABLE 305: Africa Recent Past, Current & Future Analysis for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 306: Africa Historic Review for Autoinjectors by End-Use - Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 307: Africa 16-Year Perspective for Autoinjectors by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics and Ambulatory Care Settings for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings